Differential glutamate-dependent and glutamate-independent adenosine A 1 receptor-mediated modulation of dopamine release in different striatal compartments

Journal of Neurochemistry

Volumn 101, Issue 2, 2007, Pages 355-363

  Borycz, Janusz ^a   Pereira, M Fátima ^b   Melani, Alessia ^c   Rodrigues, Ricardo J ^b   Köfalvi, Attila ^b   Panlilio, Leigh ^a   Pedata, Felicita ^c   Goldberg, Steven R ^a   Cunha, Rodrigo A ^b   Ferré, Sergi ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Adenosine A1 receptor; Caffeine; Dopamine; Glutamate; Rat; Striatum

Indexed keywords

8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR; CAFFEINE; DOPAMINE; GLUTAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN PERFUSION; BRAIN SYNAPTOSOME; CAUDATE NUCLEUS; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; STRIATE CORTEX;

ADENOSINE; ANIMALS; CAFFEINE; CORPUS STRIATUM; DOPAMINE; GLUTAMIC ACID; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PHOSPHODIESTERASE INHIBITORS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, ADENOSINE A1; SYNAPTIC TRANSMISSION; THEOPHYLLINE;

RATTUS;

EID: 34047118657     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04386.x     Document Type: Article

References (34)

1. Acquas E., Tanda G. and Di Chiara G. (2002) Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology 27, 182-193.
2. Alexander S. P. and Reddington M. (1989) The cellular localization of adenosine receptors in rat neostriatum. Neuroscience 28, 645-651.
3. Ballarin M., Reiriz J., Ambrosio S. and Mahy N. (1995) Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett. 185, 29-32.
4. Brundege J. M. and Williams J. T. (2002) Differential modulation of nucleus accumbens synapses. J. Neurophysiol. 88, 142-251.
5. Calabresi P., Centonze D., Pisani A. and Bernardi G. (1997) Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. J. Neurosci. 17, 4509-4516.
6. Cauli O. and Morelli M. (2005) Caffeine and the dopaminergic system. Behav. Pharmacol. 16, 63-77.
7. Ciruela F., Casadó V., Rodrigues R. J. et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 2080-2087.
8. Di Chiara G., Bassareo V., Fenu S. et al. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 1, 227-241.
9. Ebstein R. P. and Daly J. W. (1982) Release of norepinephrine and dopamine from brain vesicular preparations: effects of adenosine analogues. Cell. Mol. Neurobiol. 2, 193-204.
10. Flagmeyer I., Haas H. L. and Stevens D. R. (1997) Adenosine A1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro. Brain Res. 778, 178-185.
11. van Galen P. J., van Bergen A. H., Gallo-Rodriguez C., Melman N., Olah M. E., Ijzerman A. P., Stiles G. L. and Jacobson K. A. (1994) A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol. Pharmacol. 45, 1101-1111.
12. Gerfen C. R. (2004) Basal Ganglia, in The Rat Nervous System (Paxinos G., ed.), pp. 455-508. Elsevier, San Diego.
13. Gracy K. N. and Pickel V. M. (1996) Ultrastructural immunocytochemical localization of the N-methyl-D-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens. Brain Res. 739, 169-181.
14. Jin S., Johansson B. and Fredholm B. B. (1993) Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267, 801-808.
15. Karcz-Kubicha M., Quarta D., Hope B. T., Antoniou K., Muller C. E., Morales M., Schindler C. W., Goldberg S. R. and Ferre S. (2003) Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos. Eur. J. Neurosci. 18, 296-302.
16. Köfalvi A., Rodrigues R. J., Ledent C., Mackie K., Vizi E. S., Cunha R. A. and Sperlágh B. (2005) Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25, 2874-2884.
17. Lovinger D. M. and Choi S. (1995) Activation of adenosine A1 receptors initiates short-term synaptic depression in rat striatum. Neurosci. Lett. 199, 9-12.
18. Malenka R. C. and Kocsis J. D. (1988) Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro. J. Neurosci. 8, 3750-3756.
19. Manzoni O., Pujalte D., Williams J. and Bockaert J. (1998) Decreased presynaptic sensitivity to adenosine after cocaine withdrawal. J. Neurosci. 18, 7996-8002.
20. Melani A., Corsi C., Gimenez-Llort L., Martinez E., Ogren S. O., Pedata F. and Ferré S. (1999) Effect of N-methyl-D-aspartate on motor activity and in vivo adenosine striatal outflow in the rat. Eur. J. Pharmacol. 385, 15-19.
21. Michaelis M. L., Michaelis E. K. and Myers S. L. (1979) Adenosine modulation of synaptosomal dopamine release. Life Sci. 24, 2083-2092.
22. Moser A., Liebetrau A. and Cramer H. (1991) Adenosine receptor-coupled adenylate cyclase in the caudate nucleus of the rat brain. Neuropharmacology 30, 769-773.
23. Okada M., Mizuno K. and Kaneko S. (1996) Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212, 53-56.
24. Pontieri F. E., Tanda G. and Di Chiara G. (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl Acad. Sci. USA 92, 12 304-12 308.
25. Quarta D., Ferré S., Solinas M., You Z. B., Hockemeyer J., Popoli P. and Goldberg S. R. (2004a) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J. Neurochem. 88, 1151-1158.
26. Quarta D., Borycz J., Solinas M. et al. (2004b) Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J. Neurochem. 91, 873-880.
27. Raiteri L. and Raiteri M. (2000) Synaptosomes still viable after 25 years of superfusion. Neurochem. Res. 25, 1265-1274.
28. Rodrigues R. J., Alfaro T. M., Rebola N., Oliveira C. R. and Cunha R. A. (2005) Co-localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J. Neurochem. 92, 433-441.
29. Singer J. D. (1998) Using SAS PROC MIXED to fit multilevel models, hierarchial models, and individual growth models. J. Educ. Behav. Stat. 24, 323-355.
30. Solinas M., Ferré S., You Z. B., Karcz-Kubicha M., Popoli P. and Goldberg S. R. (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 22, 6321-6324.
31. Tarazi F. I., Campbell A., Yeghiayan S. K. and Baldessarini R. J. (1998) Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse 30, 227-235.
32. Voorn P., Vanderschuren L. J., Groenewegen H. J., Robbins T. W. and Pennartz C. M. (2004) Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 27, 468-474.
33. Wojcik W. J. and Neff N. H. (1983) Differential location of adenosine A1 and A2 receptors in striatum. Neurosci. Lett. 41, 55-60.
34. Zetterström T. and Fillenz M. (1990) Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol. 180, 137-143.